LabKey Server systems are in production use at many of the world's leading biomedical research organizations. They improve the productivity of small research teams and large institutes alike, while managing terabytes of data daily.
To learn more about client services available from LabKey, contact us.
At the Fred Hutchinson Cancer Research Center (FHCRC), interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. The FHCRC uses LabKey Server in a number of departments to manage proteomics, flow cytometry and clinical study information.
The Statistical Center for HIV/AIDS Research & Prevention (SCHARP) is part of the Public Health Sciences Division of the Fred Hutchinson Cancer Research Center in Seattle, Washington. SCHARP provides statistical collaboration to HIV/AIDS researchers around the world and conducts a complementary program of statistical methodology and mathematical modeling research. SCHARP also collects, manages, and analyzes data from clinical trials and epidemiological studies dedicated to the elimination of HIV/AIDS as a threat to human health. LabKey Server stands at the the foundation of SCHARP's IT infrastructure.
Founded in 1861, the University of Washington is one of the oldest state-supported institutions of higher education on the West Coast and is one of the preeminent research universities in the world. Multiple labs within the university use LabKey Server to provide centralized, shared repositories for their flow cytometry and proteomics data.
The Center for HIV-AIDS Vaccine Immunology (CHAVI) is a consortium of universities and academic medical centers established by the National Institute of Allergy and Infectious Diseases (NIAID) under Barton Haynes, MD, of Duke University. The Center's goal is to solve major problems in HIV vaccine development and design. LabKey Server is used to manage observational study and experimental data in support of the Center�s objectives.
The Collaboration for AIDS Vaccine Discovery (CAVD) is an international network of eleven Vaccine Discovery Consortia (VDCs) and five Central Service Facilities (CSFs) funded by the Bill & Melinda Gates Foundation. CAVD teams apply new technologies, concepts and approaches to the design of safe and effective preventive vaccines against HIV/AIDS. They use LabKey Server as their central tool for collecting, managing, analyzing, tracking and sharing clinical trial datasets and experimental results.